Dalteparin Sodium is used for: Unstable angina; Pulmonary embolism; Deep-vein thrombosis; Prophylaxis of clotting in extracorporeal circulation in haemodialysis or haemofiltration; Prophylaxis of venous thromboembolism during surgery.
Recorded in the NepalDoc medicine catalog for Dalteparin Sodium.
FRAGMIN is a low molecular weight heparin (LMWH) indicated for, Prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction, Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery or medical patients with severely restricted mobility during acute illness, Extended treatment of symptomatic venous thromboembolism (VTE) to reduce the recurrence in adult patients with cancer.
From the U.S. FDA-approved label for Dalteparin Sodium. Full label: DailyMed.
FRAGMIN is a low molecular weight heparin (LMWH) indicated for, Prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction, Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery or medical patients with severely restricted mobility during acute illness, Extended treatment of symptomatic venous thromboembolism (VTE) to reduce the recurrence in adult patients with cancer. In these patients, the FRAGMIN therapy begins with the initial VTE treatment and continues for six months, Treatment of symptomatic venous thromboembolism (VTE) to reduce the recurrence in pediatric patients from birth (gestational age at least 35 weeks).
From the U.S. FDA-approved label for Dalteparin Sodium. Full label: DailyMed.
Treatment should be continued until the patient is clinically stabilized. The usual duration of administration is 5 days to 8 days. Concurrent aspirin therapy is recommended except when contraindicated.
Directions from the U.S. FDA-approved label for Dalteparin Sodium — your doctor or pharmacist may advise differently.
FRAGMIN is contraindicated in: Patients with active major bleeding., Patients with a history of heparin induced thrombocytopenia or heparin induced thrombocytopenia with thrombosis., Patients with prior hypersensitivity to dalteparin sodium (e.g., pruritis, rash, anaphylactic reactions)., Patients undergoing Epidural/Neuraxial anesthesia, do not administer FRAGMIN; o As a treatment for unstable angina and non-Q-wave MI.
Excerpt from the U.S. FDA-approved label for Dalteparin Sodium. Talk to a pharmacist or doctor before use.
Hemorrhage: Use caution in conditions with increased risk of hemorrhage, Thrombocytopenia: Monitor thrombocytopenia of any degree closely, Benzyl Alcohol Preservative: Do not use multiple-dose formulations in neonates and infants as they contain benzyl alcohol, Laboratory Tests: Periodic blood counts recommended 5.1 Risk of Hemorrhage including Spinal/Epidural Hematomas Spinal or epidural hemorrhage and subsequent hematomas can occur with the associated use of low molecular weight heparins or heparinoids and neuraxial (spinal/epidural) anesthesia or spinal puncture.
Warnings and precautions excerpt from the U.S. FDA-approved label for Dalteparin Sodium — not a complete list. Talk to a pharmacist or doctor before use.
The following clinically significant adverse reactions are described in more detail in other sections of the prescribing information., Risk of Hemorrhage including Spinal/Epidural Hematomas, Thrombocytopenia, Benzyl Alcohol Preservative Risk to Premature Infants Most common adverse reactions (>1%) are: bleeding (including hemorrhage), thrombocytopenia (Type I), hematoma at the injection site, pain at the injection site,…
Excerpt from the U.S. FDA-approved label for Dalteparin Sodium — not a complete list. Talk to a pharmacist or doctor about side effects.
6 brands · 2 makers in the NepalDoc catalog — see the full Dalteparin Sodium guide →
Store at 20°C to 25°C (68°F to 77°F); excursion permitted between 15°C to 30°C (59°F to 86°F). Latex Allergy: The needle shield of the prefilled syringe may contain natural rubber latex.
Storage information from the U.S. FDA-approved label for Dalteparin Sodium.
What is Daltehep?
Daltehep 5000IU Injection is a Dalteparin Sodium medicine made by Gland Pharma Pvt. Ltd. It comes as 5000IU Injection.
What is Daltehep used for?
Dalteparin Sodium is used for Unstable angina, Pulmonary embolism, Deep-vein thrombosis, Prophylaxis of clotting in extracorporeal circulation in haemodialysis or haemofiltration, Prophylaxis of venous thromboembolism during surgery.
What is the generic name of Daltehep?
The generic name of Daltehep is Dalteparin Sodium.
Which brands of Dalteparin Sodium are available in Nepal?
6 brands of Dalteparin Sodium are listed in the NepalDoc catalog, from 2 makers — including Daltehep 2500IU Injection, Fragmin 100000 IU Injection, Fragmin 2500 IU Injection, Fragmin 5000 IU Injection, Fragmin 7500IOU Injection.
What are the side effects of Dalteparin Sodium?
The following clinically significant adverse reactions are described in more detail in other sections of the prescribing information., Risk of Hemorrhage including Spinal/Epidural Hematomas, Thrombocytopenia, Benzyl Alcohol Preservative Risk to Premature Infants Most common adverse reactions (>1%) are: bleeding (including hemorrhage), thrombocytopenia (Type I), hematoma at the injection site, pain at the injection site,…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
